Pre-Tax Profit Margin (Quarterly)

Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues

Dr. Reddy's Laboratories Ltd (RDY) had Pre-Tax Profit Margin of 20.84% for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$1.01B
Net Income	$165.28M
Cost of Goods Sold	$458.98M
Gross Profit	$553.61M
Operating Expenses	$811.19M
Operating Income	$201.40M
Non-Operating Income/Expense	$9.63M
Pre-Tax Income	$211.03M
Normalized Pre-Tax Income	$211.03M
Income after Taxes	$164.08M
Income from Continuous Operations	$164.08M
Consolidated Net Income/Loss	$164.08M
Normalized Income after Taxes	$164.08M
EBIT	$201.40M
EBITDA	$256.40M
Weighted-Average Shares Outstanding (Basic)	832.63M
Weighted-Average Shares Outstanding (Diluted)	833.05M
Earnings per Share (EPS) (Basic)	$0.20
Earnings per Share (EPS) (Diluted)	$0.20
Balance Sheet Financials
Current Assets	$3.15B
Property, Plant, and Equipment	$1.26B
Long-Term Assets	$2.96B
Total Assets	$6.11B
Current Liabilities	$1.70B
Long-Term Debt	$131.00M
Long-Term Liabilities	$327.00M
Total Liabilities	$2.03B
Common Equity	$4.08B
Tangible Shareholders Equity	$2.80B
Shareholders Equity	$4.08B
Common Shares Outstanding	834.61M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$340.00M
Cash Flow from Investing Activities	$-324.00M
Cash Flow from Financial Activities	$-75.00M
Beginning Cash	$164.00M
End Cash	$112.00M
Increase/Decrease in Cash	$-52.00M
Stock-Based Compensation	$2.00M
Common Stock Dividends Paid	$-75.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.85
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.03
Debt to Equity Ratio	0.16
Gross Margin	54.67%
Operating Margin	19.89%
EBIT Margin	19.89%
EBITDA Margin	--
Pre-Tax Profit Margin	20.84%
Profit Margin	16.32%
Free Cash Flow	$206.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.17
Inventory Turnover	0.54
Receiveable Turnover	0.92
Days Sales in Receivables	97.86
Return on Equity	4.02%
Return on Tangible Equity	5.86%
Return on Assets	2.69%
Return on Investments	3.90%
Book Value Per Share	$4.89
Free Cash Flow per Share	$0.25
Operating Cash Flow per Share	$0.41

Data from Zacks Investment Research, Inc.